Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes Track

Preclinical evaluation of somatostatin receptor agonist versus antagonist radioligands for breast cancer imaging

Iulia Dude, Zhengxing Zhang, Navjit Hundal, Nadine Colpo, Julie Rousseau, Helen Merkens, Kuo-Shyan Lin and Francois Benard
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1175;
Iulia Dude
1BC Cancer Research Centre Vancouver BC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhengxing Zhang
1BC Cancer Research Centre Vancouver BC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Navjit Hundal
1BC Cancer Research Centre Vancouver BC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nadine Colpo
1BC Cancer Research Centre Vancouver BC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie Rousseau
1BC Cancer Research Centre Vancouver BC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helen Merkens
1BC Cancer Research Centre Vancouver BC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kuo-Shyan Lin
1BC Cancer Research Centre Vancouver BC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francois Benard
1BC Cancer Research Centre Vancouver BC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 57 no. supplement 2 1175

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 24, 2016.

Copyright & Usage 
© 2016

Author Information

  1. Iulia Dude1,
  2. Zhengxing Zhang1,
  3. Navjit Hundal1,
  4. Nadine Colpo1,
  5. Julie Rousseau1,
  6. Helen Merkens1,
  7. Kuo-Shyan Lin1 and
  8. Francois Benard1
  1. 1BC Cancer Research Centre Vancouver BC Canada

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2016 to April 2025

AbstractFullPdf
May 2016200
Jun 20163300
Jul 20161500
Aug 20162000
Sep 20161200
Oct 20161300
Nov 20162300
Dec 20162200
Jan 20171800
Feb 20171400
Mar 20171400
Apr 20171700
May 2017600
Jun 2017700
Jul 2017700
Aug 2017400
Sep 20171300
Oct 2017500
Nov 20171200
Dec 2017700
Jan 2018400
Feb 2018400
Mar 20181000
Apr 20181200
May 20182800
Jun 2018800
Jul 20181700
Aug 2018900
Sep 2018800
Oct 2018600
Nov 2018700
Dec 20181100
Jan 20191200
Feb 2019400
Mar 2019200
Apr 2019600
May 2019100
Jun 2019300
Jul 2019100
Aug 2019100
Sep 2019200
Oct 2019200
Nov 2019500
Dec 2019300
Jan 2020200
Feb 2020300
Mar 2020300
May 2020300
Jun 2020100
Aug 2020400
Sep 2020900
Dec 2020200
Jan 2021200
Feb 20211000
Mar 2021900
Apr 20211000
May 2021700
Jun 2021400
Jul 2021400
Aug 2021500
Sep 2021200
Oct 2021100
Nov 2021100
Dec 2021200
Jan 2022400
Feb 2022400
Mar 2022500
Apr 2022400
May 2022200
Jun 2022200
Jul 2022200
Aug 2022100
Dec 2022200
Jan 2023200
Mar 2023400
Apr 2023700
May 2023100
Jun 2023100
Jul 2023500
Aug 2023500
Sep 2023400
Oct 2023500
Nov 2023200
Dec 2023300
Jan 20241000
Feb 2024200
Mar 2024600
Apr 2024500
May 2024300
Jun 2024600
Jul 2024200
Aug 2024900
Sep 2024500
Oct 2024200
Nov 2024600
Dec 20241300
Jan 2025400
Feb 2025200
Mar 2025200
Apr 2025800
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Preclinical evaluation of somatostatin receptor agonist versus antagonist radioligands for breast cancer imaging
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Preclinical evaluation of somatostatin receptor agonist versus antagonist radioligands for breast cancer imaging
Iulia Dude, Zhengxing Zhang, Navjit Hundal, Nadine Colpo, Julie Rousseau, Helen Merkens, Kuo-Shyan Lin, Francois Benard
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1175;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Preclinical evaluation of somatostatin receptor agonist versus antagonist radioligands for breast cancer imaging
Iulia Dude, Zhengxing Zhang, Navjit Hundal, Nadine Colpo, Julie Rousseau, Helen Merkens, Kuo-Shyan Lin, Francois Benard
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1175;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes Track

  • Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
  • In vivo evaluation of [225Ac]Ac-DOTAZOL for α-therapy of bone metastases
  • Case study: Evaluating the new University of Florida hybrid pediatric phantoms and tissue weighting factors from ICRP Publication 103 for diagnostic dosimetry
Show more Molecular Targeting Probes Track

SPECIAL MTA: Preclinical Probes for Oncology Posters

  • Sensitivity evaluation of [C-11]TMP for PET reporter gene imaging
  • Evaluation of the peptidomimetic-organotrifluoroborate conjugate, 18F-LLP2A-PEG2-N-Pyr-p-BF3, as an α4β1-specific radiotracer for PET imaging of melanoma
  • In vivo E-cadherin expression assessed with radiolabeled E-cadherin antibodies: a potential target to image epithelial-to-mesenchymal transition in vivo.
Show more SPECIAL MTA: Preclinical Probes for Oncology Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire